SGLT2 Inhibitors Market for Diabetes Treatment Trends and Future Outlook 2035
The therapeutic strategy for managing type 2 diabetes mellitus (T2DM) has undergone a major paradigm shift over the past decade. Historically focused solely on lowering blood glucose levels, clinical diabetes management now prioritizes multi-organ protection alongside metabolic control. Central to this clinical transformation are Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors, or gliflozins....
0 Comments 0 Shares 9 Views 0 Reviews
BuzzingAbout https://www.buzzingabout.com